Advertisement
Advertisement

ALKS

ALKS logo

Alkermes Inc. plc

31.75
USD
Sponsored
+0.13
+0.40%
Jan 20, 16:00 UTC -5
Closed
exchange

After-Market

30.64

-1.12
-3.53%

ALKS Earnings Reports

Positive Surprise Ratio

ALKS beat 32 of 40 last estimates.

80%

Next Report

Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$393.01M
/
$0.34
Implied change from Q3 25 (Revenue/ EPS)
-0.30%
/
-30.61%
Implied change from Q4 24 (Revenue/ EPS)
-8.60%
/
-67.62%

Alkermes Inc. plc earnings per share and revenue

On Oct 28, 2025, ALKS reported earnings of 0.49 USD per share (EPS) for Q3 25, beating the estimate of 0.30 USD, resulting in a 59.82% surprise. Revenue reached 394.19 million, compared to an expected 363.27 million, with a 8.51% difference. The market reacted with a +4.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of 0.34 USD, with revenue projected to reach 393.01 million USD, implying an decrease of -30.61% EPS, and decrease of -0.30% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Anixa Biosciences, Inc.
Report Date
Jan 12, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.09
Surprise
-0.78%
logo
Lexaria Bioscience Corp. Common Stock
Report Date
Jan 13, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.07
Surprise
+47.21%
FAQ
For Q3 2025, Alkermes Inc. plc reported EPS of $0.49, beating estimates by 59.82%, and revenue of $394.19M, 8.51% above expectations.
The stock price moved up 4.31%, changed from $29.72 before the earnings release to $31.00 the day after.
The next earning report is scheduled for Feb 12, 2026.
Based on 18 analysts, Alkermes Inc. plc is expected to report EPS of $0.34 and revenue of $393.01M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement